Greenway enters supply agreement with 4C Labs

Mr. Carl Mastronardi reports GREENWAY ANNOUNCES INTERNATIONAL SUPPLY AGREEMENT WITH 4C LABS Greenway Greenhouse Cannabis Corp. has entered into a supply agreement with 4C Labs, a leading medical cannabis company located in the United Kingdom, focused on providing patients with world-class medical cannabis products. Through the agreement the company expects to supply high-quality, dried flower product to 4C Labs, a leading importer and distributor of cannabis-based pharmaceuticals in the United Kingdom. "We have met with many international groups looking for strong, consistent cannabis for medical use, as Canadian cannabis is seen as the gold standard for quality, safety and value. For Greenway, working with international partners opens us up to the fastest-growing markets around the world, which should provide better margins than the current Canadian domestic market," said Carl Mastronardi, president of Greenway. "The team at 4C Labs impressed us with their local distribution system and drive to ensure only the best cannabis is used in their supply chain. Our product is perfectly suited to help them deliver on their unique value proposition to U.K. patients. We are excited about the prospect of seeing the product we put so much hard work into enjoyed by people around the world." "We are impressed with the capabilities and company culture at Greenway," said Greg Dobbin, chief executive officer of 4C Labs. "Greenway has developed into a premier medical cannabis grower, a result of decades of experience with greenhouse growing. They offer outstanding medical cannabis products at a very competitive price, which the patients of the U.K. will appreciate. We are excited to add Greenway to the 4C Labs product line." Issuance of shares The company is pleased to announce that, pursuant to its engagement letter dated June 4, 2024, with Abingdon Capital Corp., an arm's-length consultant, the company has issued the consultant and its assignees an aggregate of 337,507 common shares in the capital of the company at deemed prices between 20 cents and 29 cents per common share. The common shares were issued in satisfaction of a portion of the monthly work fee owed to the consultant as consideration for the provision of corporate-finance advisory services. All common shares issued will be subject to a hold period of four months and a day from the date of issuance in accordance with applicable Canadian Securities Exchange policies and Canadian securities laws. About Greenway Greenhouse Cannabis Corp. Greenway Greenhouse Cannabis is a federally licensed cultivator for the Canadian cannabis marketplace. Greenway is headquartered in Kingsville, Ont., and leverages its agriculture and cannabis expertise in its aspiration to be a leading cannabis cultivator in Canada. We seek Safe Harbor.